NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Vascular Biogenics Ltd. (NASDAQ: VBLT) and Notable Labs, Inc. is fair to Vascular ...

Vascular Biogenics (VBLT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2021. This widely-known consensus outlook ...

Vascular Biogenics Ltd (NASDAQ:VBLT) shares are falling Wednesday after the company announced that the data from its Phase 3 OVAL trial of ofra-vec in platinum-resistant ovarian cancer did not meet ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Vascular Biogenics (VBLT) reports results for the quarter ended September 2019. While this widely-known consensus ...

If you want to know who really controls Vascular Biogenics Ltd. (NASDAQ:VBLT), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, ...